{
    "organizations": [],
    "uuid": "94b26d644c3a36308f5b567d5d5323f2787958a9",
    "author": "",
    "url": "https://www.reuters.com/article/brief-european-commission-approves-expan/brief-european-commission-approves-expanded-indication-for-amgens-xgeva-idUSFWN1RG010",
    "ord_in_thread": 0,
    "title": "BRIEF-‍European Commission Approves Expanded Indication For Amgen's Xgeva",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 3 (Reuters) - Amgen Inc:\n* ‍EUROPEAN COMMISSION APPROVES EXPANDED INDICATION FOR AMGEN’S XGEVA (DENOSUMAB) FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH MULTIPLE MYELOMA​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-03T08:04:00.000+03:00",
    "crawled": "2018-04-03T08:21:25.076+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "amgen",
        "inc",
        "commission",
        "approves",
        "expanded",
        "indication",
        "amgen",
        "xgeva",
        "denosumab",
        "prevention",
        "event",
        "patient",
        "multiple",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}